You are here

Article Text

Article menu
Download PDFPDF
Letter
Tears and conjunctival scrapings for coronavirus in patients with SARS
  1. W M Chan1,
  2. K S C Yuen1,
  3. D S P Fan1,
  4. D S C Lam1,
  5. P K S Chan2,
  6. J J Y Sung3
  1. 1Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong
  2. 2Department of Microbiology, The Chinese University of Hong Kong, Hong Kong
  3. 3Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong
  1. Correspondence to: Professor D S C Lam Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, 3/F, Hong Kong Eye Hospital, 147K Argyle Street, Kowloon, Hong Kong; dennislamcuhk.edu.hk

https://doi.org/10.1136/bjo.2003.039461

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Severe acute respiratory syndrome (SARS) was first recognised in Guangdong Province in China and later in Hong Kong in March 2003.1 Within a matter of weeks, the outbreak has evolved to become a global health threat and almost 30 countries have been afflicted with the novel coronavirus strain (SARS-CoV).2 SARS is a highly contagious potentially lethal disease. The main route of transmission is by respiratory droplets, though the virus has also been isolated in stool and in urine. Tears, being one of the body fluids, may potentially harbour the coronavirus. The presence of viruses in these body fluids may affect our precaution practices and sites of sampling for diagnostic tests.

    Case series

    A prospective interventional case series study was conducted on the identification of the SARS-CoV virus in tear secretions and conjunctival cells of patients with confirmed SARS. Approval was obtained from the ethics committee of the Chinese University of Hong Kong. Consecutive patients with …

    View Full Text

    Footnotes

    • Financial and proprietary interest: Nil.

      Financial support: Supported by the Action for Vision Eye Foundation, Hong Kong.

    • Conflict of interest: Nil.